Close Menu

In an editorial, Nature's team explains the rationale behind asking for independent verification of the primate cloning paper that has already seen lots of media attention. The editorial makes it clear that the decision to obtain second-party verification was based on past problems in the cloning arena, rather than any misgivings about the research team behind the latest paper.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.